Citadel Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.54M | Buy |
232,400
+13,500
| +6% | +$375K | ﹤0.01% | 4178 |
|
|
2025
Q4 | $6.07M | Sell |
218,900
-43,000
| -16% | -$1.1M | ﹤0.01% | 3982 |
|
|
2025
Q3 | $6.36M | Buy |
261,900
+65,900
| +34% | +$1.31M | ﹤0.01% | 3936 |
|
|
2025
Q2 | $3.33M | Buy |
196,000
+143,100
| +271% | +$2.49M | ﹤0.01% | 4800 |
|
|
2025
Q1 | $1.03M | Buy |
52,900
+1,600
| +3% | +$41.9K | ﹤0.01% | 6875 |
|
|
2024
Q4 | $1.27M | Sell |
51,300
-41,600
| -45% | -$1.06M | ﹤0.01% | 6539 |
|
|
2024
Q3 | $2.28M | Buy |
92,900
+11,000
| +13% | +$284K | ﹤0.01% | 5294 |
|
|
2024
Q2 | $1.92M | Buy |
81,900
+33,000
| +67% | +$811K | ﹤0.01% | 5401 |
|
|
2024
Q1 | $1.62M | Sell |
48,900
-11,100
| -19% | -$346K | ﹤0.01% | 5935 |
|
|
2023
Q4 | $1.63M | Sell |
60,000
-77,600
| -56% | -$1.93M | ﹤0.01% | 5739 |
|
|
2023
Q3 | $3.31M | Buy |
137,600
+110,200
| +402% | +$2.95M | ﹤0.01% | 4312 |
|
|
2023
Q2 | $875K | Sell |
27,400
-39,400
| -59% | -$1.28M | ﹤0.01% | 6740 |
|
|
2023
Q1 | $2.05M | Buy |
66,800
+6,600
| +11% | +$260K | ﹤0.01% | 5325 |
|
|
2022
Q4 | $2.35M | Sell |
60,200
-147,400
| -71% | -$6.6M | ﹤0.01% | 5172 |
|
|
2022
Q3 | $9.89M | Buy |
207,600
+132,800
| +178% | +$7.58M | ﹤0.01% | 2782 |
|
|
2022
Q2 | $2.9M | Sell |
74,800
-44,200
| -37% | -$1.76M | ﹤0.01% | 4817 |
|
|
2022
Q1 | $6.82M | Buy |
119,000
+30,500
| +34% | +$2M | ﹤0.01% | 3590 |
|
|
2021
Q4 | $7.05M | Buy |
88,500
+10,000
| +13% | +$856K | ﹤0.01% | 3706 |
|
|
2021
Q3 | $6.83M | Buy |
78,500
+1,100
| +1% | +$111K | ﹤0.01% | 3723 |
|
|
2021
Q2 | $9.96M | Buy |
77,400
+22,100
| +40% | +$1.76M | ﹤0.01% | 3083 |
|
|
2021
Q1 | $4.43M | Buy |
55,300
+2,900
| +6% | +$276K | ﹤0.01% | 4533 |
|
|
2020
Q4 | $4.28M | Buy |
+52,400
| New | +$2.58M | ﹤0.01% | 3938 |
|
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
